PUBLICATIONS of Zlatko Dembic -- << Back (A) Next (C) >>
B. REVIEWS AND THEORETICAL ARTICLES
Click on the underlined Journal links to view abstracts on pubmed or download free articles (where available).
In some older manuscripts, clicking selects a link to a Journal homepage.


  1. Steinmetz M, and Dembic Z.
    Organization, rearrangement and diversification of mouse T cell receptor genes.
    Curr Topics Microbiol Immunol 126, 45-51 (1986).

  2. Dembic Z, von Boehmer H, and Steinmetz M.
    The role of T-cell receptor alpha and beta genes in MHC-restricted antigen recognition.
    Immunology Today 7, 308-311 (1986).


  3. Steinmetz M, and Dembic Z.
    Gene transfer experiments to study T-cell recognition of MHC and antigen.
    Boehring Inst Res Communications 81, 41-45 (1987).


  4. Dembic Z, and Vidovic D.
    Specificity and function of Qa-1 restricted gamma/delta T cells.
    Res Immunol 141, 600-603 (1990).


  5. Dembic Z.
    Specificity and function of gamma/delta T cells.
    Period Biol 93, 591-600 (1991).


  6. Dembic Z, Weiss S, and Bogen B.
    Thymic selection of immunoglobulin idiotype specific T cells.
    Thymus 22,141-152 (1994).


  7. Dembic Z.
    Do we need integrity?
    Scand J Immunol 44, 549-50 (1996). Download pdf of this article, which is a comment on the hypothesis by Langman & Cohn in the same issue (1996).


  8. Bogen B, Schenck K, Munthe LA, and Dembic Z.
    Deletion of idiotype-specific T cells in multiple myeloma.
    Acta Oncologica 39, 783-788 (2000).


  9. Dembic Z,
    Immune system protects integrity of tissues.
    Mol Immunol 37, 563-569 (2000). Download pdf of this article.


  10. Dembic Z,
    About theories and the integrative function of the immune system.

    The Immunologist 8/6, 141-146 (2000).


  11. Corthay A, Lundin KU, Munthe LA, Froyland M, Gedde-Dahl T, Dembic Z, and Bogen B.
    Immunotherapy in multiple myeloma: Id-specific strategies suggested by studies in animal models.
    Cancer Immunol Immunother 53:759-69 (2004).


  12. Dembic Z.
    Response to Cohn: The immune system rejects the harmful, protects the useful and neglects the rest of microorganisms.
    Scand J Immunol 60:3-5; discussion 6-8 (2004). Download pdf of this article.


  13. Dembic Z.
    Beginning of the end of (understanding) the immune response.
    Scand J Immunol 68, 381-2. (2008). Download pdf of this article.

  14. Jotanovic Z, Mihelic R, Sestan B, and Dembic Z.
    Role of interleukin-1 inhibitors in osteoarthritis: an evidence-based review.
    Drugs Aging 29(5):343-58. (2012).


  15. Dembic Z.
    On Recognizing 'Shades-Of-Gray' (Self-Nonself Discrimination) Or 'Colour' (Integrity Model) by the Immune System.
    Scand J Immunol 78:325-338. (2013).


  16. Jotanovic Z, Mihelic R, Sestan B, and Dembic Z.
    Emerging pathways and promising agents with possible disease modifying effect in osteoarthritis treatment.
    Curr Drug Targets 15(6):635-61. (2014).


  17. Haabeth OA, Tveita AA, Fauskanger M, Schjesvold F, Lorvik KB, Hofgaard PO, Omholt H, Munthe LA, Dembic Z, Corthay A, and Bogen B.
    How Do CD4(+) T Cells Detect and Eliminate Tumor Cells That Either Lack or Express MHC Class II Molecules?
    Front Immunol 5:174. (2014).


  18. Dembic Z.
    Pharmaco-therapeutic challenges in cancer biology with focus on the immune-system related risk factors.
    Curr Pharm Des 20(42):6652-9 (2014).


  19. Jotanovic Z, Mihelic R, Sestan B, and Dembic Z.
    Osteoarthritis of the hip: An overview.
    Periodicum biologorum Vol 117:(1) s. 95-108 (2015).


  20. Anderson C.C. et al, incl. Dembic Z.
    Immunological Tolerance. Part I of a Report of a Workshop on Foundational Concepts of Immune Regulation.
    Scand J Immunol Vol 85, 84-94 (2017).


  21. Bretscher P.A. et al, incl. Dembic Z.
    Immune Class Regulation and Its Medical Significance. Part II of a Report of a Workshop on Foundational Concepts of Immune Regulation.
    Scand J Immunol 85, 242-250 (2017).


 


IOB Scand J Immunol